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ABSTRACT
Background    The definition of continence after ro-
bot-assisted laparoscopic radical prostatectomy (RARP) 
has not been consistently defined, with many studies 
only noting the amount of safety pads used. We there-
fore examined what definition of continence would be 
appropriate, employing both the International Consulta-
tion on Incontinence Modular Questionnaire Short Form 
(ICIQ-SF) and the number of pads used by patients. We 
also evaluated the relationship between the number of 
pads used and degree of incontinence.
Methods    Patients who underwent RARP between 
October 2010 and July 2014 in our department were in-
cluded in the present study. All patients were evaluated 
by ICIQ-SF and the number of pads used 1, 3, 6 and 12 
months after surgery. Frequency of incontinence and 
amount of incontinence were evaluated by ICIQ-SF 
Questions 1 and 2 respectively at 12 months. Quality of 
life (QOL) was evaluated by ICIQ-SF Question 3 at 1, 3, 
6, and 12 months after RARP.
Results    The overall study population was 156 patients. 
In Question 1, 19 patients answered that they leaked 
urine several times a day, but 5 patients did not use pads, 
and 8 patients were using only 1 pad a day. In Question 2, 
8 patients answered that they leaked a moderate amount 
of urine, but 2 patients did not use any pads, and 3 pa-
tients used only 1 pad a day. QOL showed significant 
differences between using no pad, 1 pad, or ≥ 2 pads at 1, 
3, 6, and 12 months after RARP.
Conclusion    Simply noting the number of pads used by 
a patient is an insufficient way to evaluate incontinence 
after RARP. Assessment by an appropriate question-
naire is also needed.
Key words    incontinence; International Consultation 
on Incontinence Modular Questionnaire Short Form; 
robot-assisted laparoscopic radical prostatectomy
Patients with localized prostate cancer are candidates 
for active surveillance, radiation therapy, and/or radi-
cal prostatectomy. Robot-assisted laparoscopic radical 
prostatectomy (RARP) has become widely used and is 
increasingly adopted as the best method of cure. Some 
reports have suggested that RARP offers short-term 
benefits over historical controls with open radical pros-
tatectomy (ORP) in terms of better visualization, lower 
perioperative complication and transfusion rates, and 
shorter hospital stay.1 Various surgical techniques have 
been devised to reduce incontinence after RARP.2
 Postoperative urinary incontinence after radical 
prostatectomy for prostate cancer has a relevant nega-
tive effect on satisfaction and quality of life (QOL).3 In 
addition, urinary incontinence has been suggested to 
have a higher impact on QOL than lack of sexual func-
tioning.3 Some studies have shown that patients achieved 
continence much earlier after RARP than after ORP or 
laparoscopic radical prostatectomy (LRP). Ficarra et al. 
reported that a 12-month urinary recovery after ORP 
ranged from 60% to 93%, and after LRP, from 66% 
to 95%. A previous systematic review shows that the 
12-month urinary recovery after RARP ranged from 
84% to 97%.1 In addition, Sammon et al. reported that 
only 17.3% of patients undergoing RARP showed that 
they were able to achieve urinary continence right after 
catheter removal.4 On the other hand, the definition of 
continence after RARP has not been determined cor-
rectly. The most common definition of incontinence is 
the use of urinary safety pads.1 Many reports have de-
termined that continence is defined as “no pad” or “one 
safety pad per day.”1 However, this definition excludes 
patients who may be incontinent but don’t use pads for 
whatever reason.
 We therefore examined what definition of conti-
53
Evaluation of incontinence after RARP
nence would be appropriate, employing both the Interna-
tional Consultation on Incontinence Modular Question-
naire Short Form (ICIQ-SF) and noting the number of 
pads used. We also evaluated the relationship between 
the number of pads used and degree of incontinence from 
information given by the patient on the questionnaire.
MATERIALS AND METHODS
Ethics
This study was conducted at the Division of Urology, 
Tottori University Hospital, Tottori, Japan. The study 
was approved by the Tottori University Ethics Commit-
tee (No. 2545).
Patients
All patients who underwent RARP between October 
2010 and July 2014 in the Division of Urology at Tottori 
University Hospital for clinically localized prostatic can-
cer (stages cT1c–cT3a N0 M0) were included in the pres-
ent study. All patients were evaluated by ICIQ-SF and 
the number of pads used.
Follow-up and Questionnaire
Frequency of incontinence was evaluated by ICIQ-
SF Question 1: “How often does your urine leak?” 
Responses were scored as follows: “Never,” 0; “About 
once a week or less,” 1; “Two or three times a week,” 2; 
“About once a day,” 3; “Several times a day,” 4; and “All 
the time,” 5. The amount of incontinence was evaluat-
ed by ICIQ-SF Question 2: “How much urine usually 
leaks?” Responses were scored as follows: “None,” 0; “A 
small amount,” 2; “A moderate amount,” 4; and “A large 
amount,” 6. QOL was evaluated using ICIQ-SF Ques-
tion 3: “Overall, how much does leaking urine interfere 
with your everyday life?” Responses were scored on a 
range from 0, “Not at all” to 10, “A great deal.”
Statistical analysis
All data were presented as number as the mean with 
standard deviation. Comparisons of mean values among 
the groups were done using ANOVA with the Tukey-
test. A P value of less than 0.05 (P < 0.05) was consid-
ered significant. Statistical analysis was carried out using 
the Statistical Package for the Social Sciences, version 
19 (IBM, Armonk, NY). 
RESULTS
A total of 210 patients underwent RARP, but 54 pa-
tients were excluded from this study since there was a 
lack of data based on their questionnaires. As a result, 
156 patients formed the overall study population. Mean 
patient age was 65.2 years (range, 50–75 years), mean 
prostate-specific antigen (PSA) concentration was 9.44 
ng/mL (range, 4.20–25.7 ng/mL), and mean prostate vol-
ume was 32.1 mL (range, 8.9–75 mL). In terms of clin-
ical stage, 33 patients were T1c, 67 patients were T2a, 7 
patients were T2b, 34 patients were T2c, and 15 patients 
were T3a. Seventy-seven patients received nerve-spar-
ing procedures on at least unilateral side (Table 1). One 
month after RARP, 31.4% of patients had achieved 0 
pad usage and 58.3% had achieved 0–1; this increased 
to 67.3% with 0 pads and 90.1% with 0–1 pads after 6 
months and 78.8% with 0 pads and 94.9% with 0–1 pads 
after 12 months (Table 2).
 Twelve months after RARP, in response to ICIQ-SF 
Question 1, 73 patients answered that they never leaked 
urine, but 1 patient used 1 pad. Thirty-four patients an-
swered that they leaked urine about once a week or less, 
and 4 patients used 1 pad. Sixteen patients answered 
that they leaked urine two or three times a week, and 6 
patients used 1 pad. However, 19 patients answered that 
they leaked urine several times a day, but 5 of these pa-
tients did not use any pads and 8 of these patients used 
only 1 pad (Table 3).
 Twelve months after RARP, 
in response to ICIQ-SF Question 2, 
75 patients answered that they never 
leak urine, but 1 patient used 1 pad. 
Of the 71 patients who answered that 
they leaked a small amount of urine, 
Table 1. Characteristics of study patients
Factors Mean ± SD or number
No. of patients 156
Age (years old) 65.2 ± 6.7
PSA (ng/mL) 9.4 ± 6.8
Prostate volume (mL) 32.1 ± 13.5
Clinical stage
    T1c 33
    T2a 67
    T2b 7
    T2c 34
    T2c 15
Nerve sparing
    Yes 77
    No 79
No., number; PSA, prostate specific antigen.
Table 2. Continent rates after RARP according to the definition of no 
pads or 1 pad as an objective measure of continence
No. of pads 1 month 3 month 6 month 9 month 12 month
0 (%) 31.4 51.9 67.3 72.4 78.8
0–1 (%) 58.3 81.4 90.1 94.2 94.9
No., number; RARP, robot-assisted laparoscopic radical prostatectomy.
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3 patients used ≥ 2 pads. Of the eight patients who an-
swered that they leaked a moderate amount of urine, 2 
patients did not use any pads, 3 patients used 1 pad, and 
3 patients used ≥ 2 pads (Table 3).
 In terms of QOL, 12 months after RARP in ICIQ-
SF Q3, there were significant differences between no 
pad, 1 pad, and 2 or more pads at 1, 3, 6 and 12 months 
(Table 4).
DISCUSSION
Urinary incontinence after RARP is influenced by the 
preoperative characteristics of the patient, patient age, 
experience of the surgeon, and the surgical techniques 
applied, including nerve sparing.5 A systematic review 
showed that according to the definition of continence 
as using no pads, 12-month urinary incontinence rates 
ranged from 4% to 31%, with a mean of 16%. Consid-
ering studies that considered no pads or one safety pad 
as the definition of continence, 12-month urinary incon-
tinence rates ranged from 8% to 11%, with a mean of 
9%.1 However, an unambiguous definition of continence 
after RARP has yet to be established. Many definitions 
have been employed, including the number of pads used, 
leak-free status, and questionnaire responses.6–8 Many 
authors have used the definition of no pad or 1 safety 
pad as an objective measure of continence.1 On the other 
hand, some studies have reported pad count as an un-
reliable indicator in the severity of incontinence.8–10 We 
examined the relationship between the number of pads 
used and an incontinence symptom scale based on the 
ICIQ-SF.
 In this study, the 12-month continence rate accord-
Table 3. Incontinent symptom scales based on ICIQ-
SF and the number of pads used at 12 month after 
RARP
ICIQ-SF / No. of pads 0 1 2 or more
Q1 (How often does your urine leak?)
      Never 72 1 0
      About once a week or less 30 4 0
      Two or three times a week 10 6 0
      About once a day 5 7 0
      Several times a day 5 8 6
      All the time 0 0 2
Q2 (How much urine usually leaks?)
      None 74 1 0
      A small amount 46 22 3
      A moderate amount 2 3 3
      A large amount 0 0 2
ICIQ-SF, International Consultation on Incontinence Modular 
Questionnaire Short Form; No., number; Q, Question.
Table 4. QOL scores based on ICIQ-SF by the number 
of pads used at 1, 3, 6, 12 month after RARP 
Month No. of pads ICIQ-SF Q3 score n
1
0 1.12 ± 1.34 49* *
1 3.54 ± 1.94 42*
2 or more 6.69 ± 2.96 62
3
0 0.93 ± 2.49 81* *
1 3.21 ± 2.49 46*
2 or more 6.34 ± 2.76 29
6
0 0.72 ± 1.10 105* *
1 3.14 ± 2.27 34*
2 or more 5.52 ± 2.96 17
12
0 0.85 ± 1.30 122* *
1 3.0 ± 2.19 26*
2 or more 7.5 ± 2.51 8
ICIQ-SF Question 3: “Overall, how much does leaking urine in-
terfere with your everyday life?” Patients choice a number from 0 
to 10, “Not at all” to “A great deal.” * P < 0.05.
ICIQ-SF, International Consultation on Incontinence Modular 
Questionnaire Short Form; No., number; QOL, quality of life.
ing to the definition of no pad use was 21.2%, lower than 
reported in previous studies.11–13 Some studies have pre-
viously demonstrated age and nerve sparing as associat-
ed with continence after surgery.14–16 We suggested that 
the reasons for the lower continence rate in our study 
were higher age and a lower nerve-sparing rate than in 
previous studies.
 In this study, 72 (59.0%) of the 122 patients that 
did not use pads selected “Never” for Question 1 in the 
ICIQ-SF at 12 months after RARP. Although ten (8.2%) 
of these 122 patients complained of leaking urine once 
or more a day, the definition of no pad use seems rela-
tively consistent with continence based on the ICIQ-SF. 
On the other hand, only one (3.8%) of 26 patients using 
one pad selected “Never” for Question 1 in the ICIQ-
SF at 12 months after RARP. Fifteen (57.7%) of these 26 
patients using 1 pad complained of leaking urine once 
or more a day, although leaked amounts were small. The 
definition of using 1 pad was not consistent with conti-
nence based on the ICIQ-SF.
 Haga et al. found little correlation between the 
number of pads used and severity of incontinence. One 
possible reason was that patients wore various configu-
rations and sizes of pads, unrelated to the actual volume 
of urinary incontinence.7 Pad count was thus not useful 
as an objective measure of incontinence after RARP. 
Some reports have used the number of pads and scores 
on various questionnaires including the ICIQ-SF and 
the Expanded Prostate Cancer Index Composite (EPIC) 
as definitions of continence after RARP.7, 17 Our find-
ings support their definition of continence based on the 
55
Evaluation of incontinence after RARP
number of pads used together with questionnaire-based 
symptom scales.
 Concerning QOL, urinary incontinence after RARP 
has been suggested to have a higher impact on QOL 
than sexual functioning.18 Haga et al. reported that the 
number of pad exchanges per day, pad wetness, and the 
timing of pad exchanges were important factors affect-
ing QOL.7 In our study, a significant difference in QOL 
was seen between no pad and 1 pad. The definition of 
using 1 pad is not consistent with continence based on 
ICIQ-SF. If we evaluate incontinence based solely on 
only the number of pads used, no pad use is appropriate 
as a definition of continence.
 One study limitation was that we did not include a 
validated objective measure of the pad test. Nitti et al. 
reported that men with post-prostatectomy incontinence 
accurately described the number, size, and degree of 
wetness of pads that they collected during a 24-h pad 
test.8 However, this approach seems impractical as a pad 
test for every patient. A practical approach is to perform 
the pad test for those patients showing inconsistency 
between the number of pads used and symptom scales 
based on questionnaire responses. 
 In conclusion, we feel the number of pads used is an 
insufficient indicator for evaluating incontinence after 
RARP. Incontinence after RARP should be evaluated 
using a combination of noting the number of pads used, 
questionnaires, and possibly a pad test.
 Further studies are needed to establish a unified 
definition of continence from clinical outcome evalua-
tions of RARP and provisions for accurate information 
to and from patients.
The authors declare no conflict of interest. 
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